Cargando...

Circulating Tumors Cells as Biomarkers: Progress Toward Biomarker Qualification

Personalized cancer medicine requires the development of tumor-specific biomarkers to optimize selection of targeted therapies and to better assess response to therapy. Current efforts in several tumor types have shown that patients in whom circulating tumor cells (CTCs) are detected have an inferio...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Danila, Daniel C., Pantel, Klaus, Fleisher, Martin, Scher, Howard I.
Formato: Artigo
Idioma:Inglês
Publicado: 2011
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3985131/
https://ncbi.nlm.nih.gov/pubmed/22157288
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PPO.0b013e31823e69ac
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!